and collagenase (sterile, Clostridium histolvticum) were obtained 
Wilms' tumor (nephroblastoma), one of the most frequent solid malignant tumors of childhood, almost exclusively arises from the kidney and is contained, in part, by the renal capsule. Deutsch (7), Tomasi et a [ . (29) , and Morse and Nussbaum (2 1) have reported the presence of hyaluronic acid in the serum of patients with this neoplasm. Definite proof that this tumor synthesizes hyaluronic acid has not been reported, although Allerton et al. (1) were able to isolate hyaluronic acid from freshly excised tumor. In this communication evidence is presented indicating that hyaluronic acid and other glycosaminoglycans are actively synthesized by Wilms' tumor.
MATERIALS AND METHODS

MATERIALS from ~a l b i o c h e m and Worthington ~i o c h e m i c a l
Corp., respectively. Twice crystallized papain, prepared from crude enzyme (type 11, Sigma) by the procedure of Kimmel and Smith (15) , was a gift of Dr. A. C . Stoolmiller.
Sephadex G-50 (fine grade), Sephadex G-200 (fine), and Sepharose 4B were purchased from Pharmacia Fine Chemicals, Uppsala, Sweden, and ECTEOLA-cellulose (Whatman Chromedia ET-11 cellulose; nominal capacity, 0.5 mEqlg) from W. and R. Balston Ltd., Maidstone, Kent, UK.
The Wilms' tumor was obtained within 1 hr after its surgical removal. Portions of the tumor were digested with collagenase for isolation of cells or incubated with labeled glycosaminoglycan precursors. The remainder of the tumor was stored at -20'. Serum and urine samples were obtained preoperatively from -- another patient with a confirmed Wilms' tumor.
ISOLATION AND CULTURE OF WILMS' TUMOR CELLS
Four g tumor were minced and incubated with 2 mg collagenase in 20 ml modified Eagle's medium in two 100-mm Falcon tissue culture dishes (Falcon Plastics, Division of Bio-Quest, Oxnard, CA). After 2 days at 37' in a humidified atmosphere of 10% CO, and 90% air, the cells and medium were removed from the dishes, centrifuged (10 min at 500 x g), and the pellet dispersed in 20 ml modified Eagle's medium containing 10% fetal calf, 10% calf serum, and 5 pg/ml gentamycin. This cell suspension was then incubated for 7 days over 0.5% agar containing the same medium. During this period the cells were fed twice by gently removing them from above the agar gel, centrifuging (10 min at 500 x g), resuspending the pelleted cells in fresh medium, and transfering this suspension to freshly prepared agar dishes. Floating cells were then transferred to 100-mm Falcon plastic dishes and fed every 2-3 days for about 2 weeks to yield approximately l o 7 cells/dish. Cells were grown at 37" in a humidified atmosphere of 10% CO, and 90% air.
GLYCOSAMINOGLYCAN SYNTHESIS IN CULTURED WILMS' TUMOR
CELLS
On the last day of culture, cells were suspended in 1 0 ml Modified Eagle's medium ( l a ) , fetal calf, calf serum, and medium and incubated for 24 Varidase, used as a source of streptococcal hyaluronidase Two g Wilms' tumor were finely minced and incubated for 8 (1 l ) , was obtained from Lederle Laboratories. Testicular hya-hr at 37" with 5 ml modified Eagle's medium, 1 ml Hanks' luronidase (20,000 IU/mg) was purchased from Leo-Helsinborg balanced salt solution, 300 pCi H235S04, and 300 pCi Laboratories, Sweden, and chondroitinase ABC and pig skin [3H]acetate. Two milliliters of 2.0 M K O H were added and the hyaluronic acid from Miles Laboratories, Inc. Pronase (B grade) incubation was continued at 30'. The reaction was stopped 5 2 after 7 hr by neutralization with acetic acid and the mixture was dialyzed against water at 4". This mixture was added to 13.5 g minced Wilms' tumor and stirred at 4' for 76 hr with 100 ml 0.5 M KOH. The reaction mixture was neutralized with acetic acid and dialyzed against water at 4". The insoluble residue was removed by centrifugation (10 min at 10,000 x g ) and part of the supernatant solution was applied to a column (2 x 25 cm) of ECTEOLA-cellulose (CI-form). Elution after a wash with approximately 150 ml 0.02 M pyridine acetate (0.02 M in acetate) was carried out with a linear gradient of NaCl generated from 500 ml 0.02 M pyridine acetate (0.02 M in acetate), pH 5.0, and 500 ml 2.0 M NaCl in the pyridine-acetate buffer (25) .
ANALYSIS OF GLYCOSAMINOGLYCANS
Glycosaminoglycans were characterized by sequential enzyme and chemical treatments followed by separation of the products on columns (1 x 200 cm) of Sephadex G-50 (fine) which were eluted with the 0.2 M pyridine acetate buffer (0.2 M in acetic acid, pH 5.0).
Labeled glycosaminoglycan fractions were lyophilized to remove pyridine acetate buffer and incubated at 37' for 24 hr with 3 mg Varidase in 5 ml 0.01 M phosphate buffer, pH 6.0, containing 0.15 NaCl (28). Testicular hyaluronidase digestions were carried out in a total volume of 5 ml 0.1 M sodium acetate buffer, pH 5.0, containing 0.15 N NaCI, using 20,000 IU enzyme (20) . Samples were incubated for 6 hr at 37O. Chondroitinase ABC digestions were performed as described by Saito et al. (26) in 0.08 M Tris-chloride buffer (0.08 M in chloride), pH 8.0, using 0.6 unit enzyme. Samples were incubated for 6 hr at 37" in a total volume of 4 ml.
Nitrous acid degradation of glycosaminoglycans was carried out according to the procedure of Lagunoff and Warren (16) by adding 3 ml 5% sodium nitrite and 3 ml 33% acetic acid to freeze-dried samples. incubating the reaction mixture for 2 hr at 30°, and freeze-drying.
ISOLATION AND ANALYSIS OF GLYCOSAMINOGLYCANS IN SERUM AND URINE
Serum and dialyzed urine samples were digested with papain at 60" for 20 hr (9). Glycosaminoglycans were precipitated in the presence of 0.03 M NaCl by the addition of 10% cetylpyridinibm chloride to the papain digests after dialysis and approximately 6-fold concentration. The precipitate was dissolved in 2.0 M LiCI. Four volumes of ethanol were added to the solution, and the glycosaminoglycan precipitate that formed after 16 hr at 4' was washed with 80% ethanol and dried with ether. Glycosaminoglycan fractions were characterized by sequential enzymic digestion with Varidase and testicular hyaluronidase. Undigested glycosaminoglycans were precipitated by the addition of 4 volumes of ethanol to the digests and incubating for 5 hr at 4".
ANALYTIC METHODS
Uronic acid was assayed by the method of Bitter and Muir (3). Total hexosamine, glucosamine, and galactosamine were determined using an automatic amino acid analyzer after samples were hydrolyzed for 20 hr in 6 N HCI in a sealed tube.
Paper chromatography was performed on Whatman no. 3MM
paper with descending development in the following solvents: 
RESULTS
The data in Table 1 Figure 1 shows the elution profiles obtained when labeled glycosaminoglycans were fractionated on columns of Sephadex (3-50 after sequential enzymic and chemical degradation. All of the labeled and uronic acid-containing material was eluted in the void volume of the column of Sephadex G-50 (Fig. 1A) . After treatment of the excluded fractions with Varidase, the resulting hyaluronic acid and chondroitin disaccharidks were separated from undigested material in the void volume (Fig.   1B) and identified by paper chromatography in solvent A .
Subsequent treatment of the undigested material with testicular hyaluronidase followed by treatment of the testicular hyaluronidase-resistant material with chondroitinase ABC allowed the identification of dermatan sulfate and chondroitin sulfate fractions, respectively (Fig. 1, C and D) . After chondroitinase ABC digestion, the resistant material was treated with nitrous acid to identify heparan sulfate. Practically all of the ""0,-labeled material moved to an included position on Sephadex G-5 0 (Fig. 1E) .
PROPERTIES OF HYALURONIC ACID AND SULFATED GLYCOSAMINOGLYCANS ISOLATED FROM WILMS' TUMOR
The reaction mixture obtained following alkali digestion of Wilms' tumor was fractionated by ion-exchange chromatography on a column of ECTEOLA-cellulose. Two peaks of uronic acid-containing material corresponding with the two major peaks of radioactivity are apparent (Fig. 2 , fractions E-1 and E-2). Approximately 8 0 % of the total uronic acid-containing material was eluted in fraction E-I. Both fractions E-1 and E-2 contain [3H]acetate-labeled material whereas the 35S04-labeled material was confined to fraction E-2.
Fraction E-1 contained glucosamine as the sole amino sugar and uronic acid in a molar ratio of 0.95:1.00. All of the uroniccontaining and ["]acetate-labeled material in fraction E-1 was eluted in the void volume of a column of Sepharose 4B. This void volume material was completely digested with streptococcal hyaluronidase to yield a product with the same R V value on paper chromatography in solvent A as the disaccharide produced from authentic hyaluronic acid. The ["Hlacetate-labeled and uronic-containing material in fraction E-1 migrated as a single spot with an electrophoretic mobility similar to authentic hyaluronic acid (1 8) .
Hyaluronic acid was also isolated from Wilms' tumor by fractionation of a Pronase digest of the tissue on Sepharose 4B. All of the hyaluronic acid was eluted in the void volume of the column of Sepharose 4B. Approximately 1 mg hyaluronic acid was obtained per g wet weight tissue. This preparation had a molecular weight of greater than 2.0 x 106 estimated from its viscosity number of 4800 ml/g determined by Dr. Martin B. Mathews using a Ubbeholde suspended level viscometer. These results show clearly that Wilms' tumor actively incorporates label into hyaluronic acid and that the uronic acid-containing and [3H]acetate-labeled product in fraction E-1 is hyaluronic acid.
Fraction E-2 (Fig. 2) contained all of the 35S04 label of the original reaction mixture. Sequential enzymic and chemical degradation, by the method outlined in Figure 1 , showed this fraction to contain 8 5 % chondroitin sulfate, 6 % dermatan sulfate, and 9% heparan sulfate (based on uronic acid analyses). These results are similar to those obtained for the alkali-soluble fraction reported in Table 1 .
Before enzymic digestion most of the sulfate-labeled material was eluted at the void volume of a column of Sephadex G-200 indicating that the molecular weight of the sulfated glycosaminoglycan chains is greater than 40,000 (14) . Fifty-seven percent, 23%, and 20% of the t3H]acetate in the chondroitinase ABCsensitive material in fraction E-2 co-chromatographed in solvent B with Adi Ch-6s (35), Adi Ch-4S, and Adi Ch, respectively. Based on elution from a column of Sephadex G-200, the chondroitinase ABC-resistant material, which was identified as heparan sulfate by its degradation with nitrous acid, has an average chain length of approximately 25,000 (13) .
GLYCOSAMINOGLYCAN SYNTHESIS BY CULTURED WILMS' TUMOR CELLS
Although the cells derived from Wilms' tumor were not cloned, they appeared to be uniform in structure and did not readily attach to tissue culture dishes. Both t3H]acetate and [~4C]glucosamine are readily incorporated into hyaluronic acid and sulfated glycosaminoglycans (Table 1) . Label was incorporated into the same four glycosaminoglycans found in minced tumor incubations. Hyaluronic acid was separated from the sulfated glycosaminoglycans by ion-exchange chromatography of the soluble glycosaminoglycans on ECTEOLA-cellulose. The profile of radioactivity obtained was similar to the one shown in 
INCORPORATION OF RADIOACTIVITY FROM UDP DERIVATIVES INTO HYALURONIC ACID
A particulate enzyme system, isolated from 20 g Wilms' tumor and assayed for hyaluronic acid biosynthetic activity as described by Hopwood et al. acid. Eighty-five percent of the labeled material was eluted in the void volume of a column of Sepharose 4B. More than 90% of the excluded labeled material was degraded with streptococcal hyaluronidase to produce a disaccharide with the same mobility on paper as Adi H A in solvent A. Approximately 15 nmol GIcUA and 20 nmol GlcNAc/hr/mg protein were incorporated into hyaluronic acid by the Wilms' tumor particulate enzyme system. This level of hyaluronic acid biosynthetic activity is similar to that reported for a particulate system isolated from a rat fibrosarcoma (14) and considerably higher than that described for particulate fractions isolated from other mammalian tissues (22, 27, 30) .
GLYCOSAMMOGLYCAN CONTENT O F SERUM AND URINE SAMPLES
Approximately 26 mg and 25 mg glycosaminoglycan were isolated/100 ml serum and urine, respectively (Table 2) . Eighty percent of the total hexosamine in the acid hydrolysate of the glycosaminoglycan fractions isolated from serum and urine was glucosamine. After digestion of the isolated glycosaminoglycan fraction with streptococcal hyaluronidase, 5.8 mg and 6.0 mg of glycosaminoglycan/l00 ml serum and urine, respectively, were precipitable with ethanol ( Table 2 ). Most of the streptococcal hyaluronidase-resistant material was sensitive to digestion with testicular hyaluronidase (Table 2 ). These results indicate that the serum fraction contains approximately 19 mg hyaluronic acid and 4.6 mg chondroitin sulfatell00 ml.
DISCUSSION
Hyaluronic acid, which is present normally only in trace amounts in serum or urine (6, 33) , was found in high concentration together with elevated levels of chondroitin sulfate in the serum and urine of a patient with a Wilms' tumor. Similar levels of hyaluronic acid in the serum and urine of Wilms' tumor patients have been reported by others (4, 7, 21, 24, 29) .
However, the elevated levels of chondroitin sulfate in the serum and urine have not previously been demonstrated and differ with the finding by Morse and Nussbaum (21) that sulfate ester groups could not be detected in the glycosaminoglycan fraction which they isolated from the serum of a Wilms' tumor patient. The reason for this difference is not understood: it may have resulted from the different methods used to isolate glycosaminoglycans from serum or it may reflect differences in the rate of glycosaminoglycan synthesis or catabolism in different Wilms' tumors or between individuals.
The high levels of hyaluronic acid in the tumor are in contrast to the amount of hyaluronic acid in normal kidney (32) . The finding that hyaluronic acid is present in high concentrations in serum, urine, and the tumor and that surgical removal of the tumor results in the disappearance of hyaluronic acid from the serum of these patients (24) , has provided only circumstantial evidence that the circulating hyaluronic acid is synthesized by the tumor. The evidence reported in the present paper shows directly that hyaluronic acid and chondroitin sulfate are synthesized at very high levels in minced tissue, cultured cells, and cell-free preparations from Wilms' tumor. Although cultured cells were not cloned. their isolation over agar and morphology indicated that they were tumor cells rather than fibroblasts.
Hyaluronic acid has recently been implicated in such processes as cell aggregation (23, 34) and mesenchymal cell mobility (17, 31) . Powars et al. (24) have speculated that hyaluronic acid may be involved in the growth and control of metastasis of Wilms' tumor. Beierle et al. (2) have reported that the serum of patients with Wilms' tumor or a crude glycosaminoglycan fraction isolated from Wilms' tumor selectively enhances the growth of cultured kidney or lung cells. Burtin and Gendron (5) have prepared antisera against extracts of Wilms' tumor and have suggested that the antigen may be viral in origin. Nephroblastomas in hamsters that had received kidney hamster cells transformed with simian virus 40 have been observed (19) . Hamsters inoculated intravenously with simian virus 40 developed neoplasms (8). Enders (10) observed that a neoplasm in hamsters that developed after implantation of simian virus 40-transformed hamster kidney cells displayed Wilms'-like histology.
We have shown recently that after transformation with simian virus 40 cultured human skin fibroblasts exhibit greatly increased hyaluronic acid biosynthetic capacity together with the loss of cell density-dependent inhibition of growth (12) . All of these findings tend to favor speculation that the loss of control over cell proliferation in these tumors may be related to their marked increase in synthesis of hyaluronic acid. Regardless of this speculation, the finding reported in the present paper that Wilms' tumor is very active in hyaluronic acid synthesis provides another system in which the mechanism and control of hyaluronic acid synthesis may be studied.
